Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 3Brain Neoplasms 2

Interventions

Temozolomide 203Radiotherapy 118Bevacizumab 93Radiation 40Magnetic Resonance Spectroscopy 28Irinotecan 27Carmustine 25Surgical Procedures, Operative 24Lomustine 21Erlotinib Hydrochloride 19Chemotherapy, Adjuvant 18Carboplatin 17temsirolimus 13Drug Therapy 13O(6)-benzylguanine 12Nivolumab 12sargramostim 11Sirolimus 11Radiotherapy, Intensity-Modulated 11Radiotherapy, Conformal 11Sorafenib 10Radiosurgery 10Imatinib Mesylate 10Everolimus 10pembrolizumab 9motexafin gadolinium 9Vorinostat 9Thalidomide 8IL13-PE38 8Gefitinib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Glioblastoma × Perfusion Magnetic Resonance Imaging × Clear all
NCT04143425 2024-05-14

Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Asan Medical Center

Completed
15 enrolled
CNS

Glioblastoma

NCT02843230 2022-04-08

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Massachusetts General Hospital

Completed
30 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT01851733 2021-08-27

MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme

Washington University School of Medicine

Phase 1 Completed
37 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡